The senior managements of Paradigm Pharmaceuticals Inc. (Paradigm Pharma) and its operations across its markets consist of executives and managers with a wide ranging experience in both multinational and branded pharmaceutical generics companies.
The company is led by its founder Amal Naj, who previously was a Senior Vice President at Pfizer Inc.'s worldwide headquarters in New York and prior to that a career journalist on the staff of the Wall Street Journal in the U.S. In addition to overseeing Paradigm Pharma, Mr. Naj is also the CEO of its affiliated company, Berlin Pharmaceutical Industry Co. Ltd., a leading branded-generics company in Thailand.
Paradigm Pharma was founded in 2008 with the business concept of offering both prevention and treatment, especially in chronic diseases. The pharmaceutical industry has generally been focused on treating sickness; prevention hasn't been its raison d'être nor its mission, rightly or wrongly. Paradigm Pharma is engaged in identifying and offering nutraceuticals (natural products with scientific and clinical support ) side-by-side with pharmaceuticals with the aim of offering preventative and treatment options to lessen human dependence on pharmaceuticals.
The company licenses-in products from a roster of leading international companies, and secures supplies at lowest possible costs so it can offer medicines and dietary supplements at highly affordable prices to patients, especially in poor countries in Asia, a cornerstone of its founding mission.
Paradigm Pharma is a closely-held U.S. company, with autonomously operated units in Asia, and markets products under its own brandnames.